EUVIMEDEUVIMED entdecken
Systematische Übersicht

Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition

John A Batsis iD, Alessandro Gavras iD, Danae C Gross, C Ray Cheever iD, Bruna R Da Silva iD, Luiz Fernando Meira Filho iD, Emily P Jones iD, Dakota Batchek, Simone Khandpekar, Rohan Patel, Bilal Awkal, Annamarie Pape und 3 weitere

Annals of Internal Medicine · 2026-07 · 179 (7) · 996-1013

DOI: 10.7326/annals-25-00478 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Annals of Internal Medicine, 2026-07. Verfasst von John A Batsis und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Geriatric Medicine, University of North Carolina at Chapel Hill School of Medicine, and Department of Nutrition, Gillings School of Globa…. Hauptthemen laut MEDLINE: Weight Loss, Body Composition, Incretins, Obesity. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 140 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Incretin-based therapies induce substantial weight loss and are widely prescribed; disproportionate losses in fat-free mass (FFM) and skeletal muscle are a concern. PURPOSE: To evaluate body composition changes associated with incretin therapies in adults with obesity. DATA SOURCES: Scopus, Embase (Elsevier), PubMed (National Institutes of Health, National Library of Medicine), CINAHL, PsycINFO (EBSCOhost), and ClinicalTrials.gov from January 2003 to February 2026. STUDY SELECTION: English-language randomized controlled trials reporting body composition outcomes of liraglutide, semaglutide, tirzepatide, or dulaglutide therapy in adults (aged ≥18 years). DATA EXTRACTION: Primary outcomes included changes in fat mass, FFM, lean soft tissue (LST), muscle-related indices, and visceral adiposity measured by bioelectrical impedance analysis (BIA), dual-energy x-ray absorptiometry (DXA), computed tomography (CT), or magnetic resonance imaging (MRI). Prespecified benchmarks were applied to contextualize expected muscle-related losses (about 25% of total weight loss for FFM or LST derived from BIA or DXA, and about 15% for skeletal muscle measured by CT or MRI). DATA SYNTHESIS: Among 8102 titles and abstracts, 35 primary studies met criteria (median duration, 26 weeks; median of 78 participants); 42.9% were at low risk of bias and 10 (28.6%) prespecified body composition as a primary outcome. Mean participant age ranged from 20 to 63.7 years and mean body mass index from 27.9 to 41.6 kg/m2. Weight loss was consistently larger in the incretin intervention groups than in placebo or lifestyle intervention comparators and was consistently accompanied by reductions in total fat mass and visceral adiposity. The degree of muscle-based losses varied widely; no study reported objective physical function outcomes. Within the incretin groups across agents and measurement methods, the median proportion of total weight loss attributable to reductions in muscle-based indices was 28.3% (IQR, 15.9% to 39.9%), with 65% exceeding the benchmark of about 25%; among studies using BIA or DXA, the median was about 29% (IQR, 16.6% to 43.1%) of total weight loss, with 67% exceeding the 25% benchmark, and in studies using CT or MRI, the median was about 25.3% (IQR, 16.7% to 27.2%), two thirds exceeding the 15% benchmark. In contrast, the 13 studies reporting weight loss in the lifestyle or placebo comparator groups accounted for a median weight loss of -2.5% (IQR, -4.5% to -0.9%), 38% of which exceeded the respective benchmark. LIMITATION: Heterogeneous body composition methods and reporting precluded meta-analysis. CONCLUSION: Loss of muscle-related indices exceeded prespecified benchmarks in about two thirds of incretin-based interventions and in nearly half of nonpharmacologic interventions that produced weight loss. Future trials are needed to better understand mechanisms underlying these changes and their clinical implications. PRIMARY FUNDING SOURCE: None. (Open Science Framework: https://doi.org/10.17605/OSF.IO/S3A5E).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Weight LossBody CompositionIncretinsObesityHumansSemaglutideTirzepatideLiraglutideGlucagon-Like Peptides

Substanzen

IncretinsSemaglutideTirzepatideLiraglutideGlucagon-Like Peptides

Autor:innen und Institutionen

  • Division of Geriatric Medicine, University of North Carolina at Chapel Hill School of Medicine, and Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel H…
  • Division of Geriatric Medicine, Department of Medicine, University of Verona, Verona, Italy (A.G., M.Z.).
  • Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (D.C.G., C.R.C., D.B., S.K., R.P., A.P., M.B.).
  • Department of Agricultural, Food, and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada (B.R.D.S., L.F.M.F., C.M.P.).
  • Health Sciences Library, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (E.P.J.).
  • Division of Geriatric Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina (B.A.).

ORCID-Profile: John A Batsis, Alessandro Gavras, C Ray Cheever, Bruna R Da Silva, Luiz Fernando Meira Filho, Emily P Jones, Carla M Prado

Zitieren

APA

Batsis, J. A., Gavras, A., Gross, D. C., Cheever, C. R., Da Silva, B. R., Meira Filho, L. F., Jones, E. P., Batchek, D., Khandpekar, S., Patel, R., Awkal, B., Pape, A., Bahna, M., Zamboni, M., & Prado, C. M. (2026). Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition. Annals of Internal Medicine, 179(7), 996-1013. https://doi.org/10.7326/annals-25-00478

Vancouver

Batsis JA, Gavras A, Gross DC, Cheever CR, Da Silva BR, Meira Filho LF, et al. Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition. Annals of Internal Medicine. 2026;179(7):996-1013. doi:10.7326/annals-25-00478

BibTeX
@article{Batsis2026,
  author = {Batsis, John A and Gavras, Alessandro and Gross, Danae C and Cheever, C Ray and Da Silva, Bruna R and Meira Filho, Luiz Fernando and Jones, Emily P and Batchek, Dakota and Khandpekar, Simone and Patel, Rohan and Awkal, Bilal and Pape, Annamarie and Bahna, Marianne and Zamboni, Mauro and Prado, Carla M},
  title = {Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition},
  journal = {Annals of Internal Medicine},
  year = {2026},
  volume = {179},
  number = {7},
  pages = {996--1013},
  doi = {10.7326/annals-25-00478}
}
Kostenlos starten →